🇺🇸 FDA
Patent

US 7419983

Gonadotropin-releasing hormone receptor antagonists and methods related thereto

granted A61PA61P1/04A61P13/08

Quick answer

US patent 7419983 (Gonadotropin-releasing hormone receptor antagonists and methods related thereto) held by Neurocrine Biosciences, Inc. expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Neurocrine Biosciences, Inc.
Grant date
Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
40
CPC classes
A61P, A61P1/04, A61P13/08, A61P15/00, A61P15/08